Sector: Pharmaceuticals & Biotechnology
|Small Cap
Sanjivani Paranteral Ltd.
₹146
₹144.00
₹153.70
Data is not available
Markets Today
Historical Performance
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 10.51 | 20.86 | 15.50 | 17.89 | 18.18 |
| Operating Expense | 9.60 | 17.27 | 13.25 | 15.24 | 15.56 |
| Operating Profit | 0.91 | 3.59 | 2.25 | 2.65 | 2.62 |
| Depreciation | 0.35 | 0.19 | 0.17 | 0.16 | 0.18 |
| Interest | 0.06 | 0.21 | 0.05 | 0.22 | 0.20 |
| Tax | 0.31 | 0.87 | 0.55 | 0.57 | 0.47 |
| Net Profit | 0.94 | 2.62 | 1.64 | 1.73 | 2.19 |
₹146.00
↗ Bullish Moving Average
3
↘ Bearish Moving Average
13
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 27.7 | 28.9 | 28.9 | 31.2 | 31.2 | 31.3 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 6.3 | 6.2 | 6.2 | 6 | 6 | 6 |
| Public | 66.1 | 65 | 65 | 62.8 | 62.8 | 62.7 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 4.4 K | 4.75 K | 92.65% |
| Week | 13.4 K | 16.64 K | 80.51% |
| 1 Month | 8.41 K | 11.74 K | 71.61% |
| 6 Month | 7.01 K | 8.87 K | 79.06% |
MACD Crossover Above Signal Line
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Mid-range Performer (DVM)
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Companies with Low Debt
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
MACD crossed above signal line previous end of day
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 19 Sep, 2025 | 0.5 | FINAL | 19 Sep, 2025 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹46.14 | ₹486.75 | ₹218.75 | ₹263.90 | ₹42.15 | ₹6.46 |
| % Change | 4.98% | 0.64% | -4.99% | 0.00% | 4.98% | 0.00% |
| Revenue TTM (₹ Cr) | - | - | - | - | ₹1.27 | ₹83.60 |
| Net Profit TTM (₹ Cr) | - | - | - | - | ₹-0.25 | ₹-34.95 |
| PE TTM | 15.60 | - | 22.30 | 37.70 | -99.80 | -1.50 |
| 1 Year Return | 23.66 | 836.67 | 545 | |||
| ROCE | - | 3.56 | - | - | - | -5.63 |
Aptus Pharma Ltd.
₹ 176.50
-0.84%
Amanta Healthcare Ltd.
₹ 132.26
-0.74%
Anlon Healthcare Ltd.
₹ 14.29
+1.71%
Patel Chem Specialities Ltd.
₹ 87.01
-2.22%
Asston Pharmaceuticals Ltd.
₹ 73.01
+4.30%
Amrutanjan Health Care Ltd.
₹ 563.80
+1.08%
Astonea Labs Ltd.
₹ 230.50
+0.66%
Amwill Health Care Ltd.
₹ 32.32
-0.19%
Innova Captab Ltd.
₹ 844.00
+0.06%
Valiant Laboratories Ltd.
₹ 80.00
+1.60%
Shelter Pharma Ltd.
₹ 30.00
-5.18%
Trident Lifeline Ltd.
₹ 248.00
-0.72%
Dipna Pharmachem Ltd.
₹ 7.75
+3.33%
Achyut Healthcare Ltd.
₹ 5.71
-1.21%
Sigachi Industries Ltd.
₹ 20.57
+1.33%
Windlas Biotech Ltd.
₹ 821.00
-0.22%
Vineet Laboratories Ltd.
₹ 35.00
+0.43%
Chandra Bhagat Pharma Ltd.
₹ 44.00
+0.00%
Solara Active Pharma Sciences Ltd.
₹ 544.00
-2.60%
Rajnish Wellness Ltd.
₹ 0.46
+2.22%
Zim Laboratories Ltd.
₹ 102.60
-0.77%
Bharat Parenterals Ltd.
₹ 1305.00
-0.65%
Medico Remedies Ltd.
₹ 49.00
+1.51%
By signing up I certify terms, conditions & privacy policy